Changchun Haiwang Biological Pharmaceutical

Changchun Haiwang Biological Pharmaceutical is a Chinese biopharmaceutical company and a key subsidiary of Shenzhen Neptunus Bioengineering. Based in Changchun, the company specializes in the research, development, and large-scale production of biological products, particularly recombinant human proteins and immunomodulators. Its commercial portfolio features essential treatments such as Recombinant Human Interferon α2b and Recombinant Human Interleukin-2, which are used to treat various cancers and viral infections. The company maintains modern, GMP-certified manufacturing facilities to support its role as a significant player in the domestic Chinese pharmaceutical market.